PL4126821T3 - Sposób wytwarzania kwasu (r)-4-(1-(6-(4-(trifluorometylo)benzylo)-6-azaspiro[2.5]oktano-5-karboksyamido)cyklopropylo)benzoesowego lub jego soli - Google Patents
Sposób wytwarzania kwasu (r)-4-(1-(6-(4-(trifluorometylo)benzylo)-6-azaspiro[2.5]oktano-5-karboksyamido)cyklopropylo)benzoesowego lub jego soliInfo
- Publication number
- PL4126821T3 PL4126821T3 PL21720694.5T PL21720694T PL4126821T3 PL 4126821 T3 PL4126821 T3 PL 4126821T3 PL 21720694 T PL21720694 T PL 21720694T PL 4126821 T3 PL4126821 T3 PL 4126821T3
- Authority
- PL
- Poland
- Prior art keywords
- azaspiro
- carboxamido
- octane
- cyclopropyl
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20166480.2A EP3885339A1 (en) | 2020-03-27 | 2020-03-27 | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof |
| PCT/EP2021/057046 WO2021191062A1 (en) | 2020-03-27 | 2021-03-19 | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4126821T3 true PL4126821T3 (pl) | 2024-12-02 |
Family
ID=70057038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21720694.5T PL4126821T3 (pl) | 2020-03-27 | 2021-03-19 | Sposób wytwarzania kwasu (r)-4-(1-(6-(4-(trifluorometylo)benzylo)-6-azaspiro[2.5]oktano-5-karboksyamido)cyklopropylo)benzoesowego lub jego soli |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12404245B2 (pl) |
| EP (2) | EP3885339A1 (pl) |
| KR (1) | KR20220160031A (pl) |
| CN (1) | CN115515936A (pl) |
| AR (1) | AR121654A1 (pl) |
| AU (1) | AU2021245014A1 (pl) |
| BR (1) | BR112022019285A2 (pl) |
| CA (1) | CA3172903A1 (pl) |
| ES (1) | ES2986976T3 (pl) |
| PL (1) | PL4126821T3 (pl) |
| WO (1) | WO2021191062A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114380717A (zh) * | 2022-01-28 | 2022-04-22 | 郑州猫眼农业科技有限公司 | 3-(叔丁氧基羰基-甲氧基羰基甲基-氨基)-丙酸甲酯及其中间体的制备方法 |
| CN116143695B (zh) * | 2023-02-17 | 2024-04-05 | 上海麦克林生化科技股份有限公司 | 一种1,1-二氟-5-氮杂螺[2.5]辛烷盐酸盐的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101622230B (zh) | 2007-02-26 | 2012-08-22 | 默克弗罗斯特加拿大有限公司 | 作为ep4受体拮抗剂的吲哚和二氢吲哚环丙基酰胺衍生物 |
| JP5549592B2 (ja) * | 2008-09-02 | 2014-07-16 | 日産化学工業株式会社 | オルト置換ハロアルキルスルホンアニリド誘導体及び除草剤 |
| EP2484674A1 (en) * | 2011-02-02 | 2012-08-08 | Rottapharm S.P.A. | Spiro aminic compounds with NK1 antagonist activity |
| ES2559513T3 (es) * | 2011-07-04 | 2016-02-12 | Rottapharm Biotech S.R.L. | Derivados de amina cíclica como antagonistas del receptor EP4 |
| ITMI20112329A1 (it) * | 2011-12-21 | 2013-06-22 | Rottapharm Spa | Nuovi derivati spiro amminici |
| US9056860B2 (en) * | 2012-06-05 | 2015-06-16 | Gilead Pharmasset Llc | Synthesis of antiviral compound |
| CA2928593A1 (en) * | 2013-12-17 | 2015-06-25 | Eli Lilly And Company | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
| CN106928127B (zh) * | 2015-12-31 | 2021-07-16 | 四川海思科制药有限公司 | 取代哌啶类酰胺衍生物及其制备方法和在药学上的应用 |
| CN107954990A (zh) * | 2017-11-14 | 2018-04-24 | 安徽诺全药业有限公司 | 一种雷迪帕维的制备方法 |
-
2020
- 2020-03-27 EP EP20166480.2A patent/EP3885339A1/en not_active Withdrawn
-
2021
- 2021-03-19 CA CA3172903A patent/CA3172903A1/en active Pending
- 2021-03-19 AU AU2021245014A patent/AU2021245014A1/en active Pending
- 2021-03-19 PL PL21720694.5T patent/PL4126821T3/pl unknown
- 2021-03-19 EP EP21720694.5A patent/EP4126821B1/en active Active
- 2021-03-19 ES ES21720694T patent/ES2986976T3/es active Active
- 2021-03-19 CN CN202180031908.7A patent/CN115515936A/zh active Pending
- 2021-03-19 BR BR112022019285A patent/BR112022019285A2/pt unknown
- 2021-03-19 KR KR1020227036422A patent/KR20220160031A/ko active Pending
- 2021-03-19 US US17/914,063 patent/US12404245B2/en active Active
- 2021-03-19 WO PCT/EP2021/057046 patent/WO2021191062A1/en not_active Ceased
- 2021-03-25 AR ARP210100737A patent/AR121654A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112022019285A2 (pt) | 2022-11-16 |
| CN115515936A (zh) | 2022-12-23 |
| US12404245B2 (en) | 2025-09-02 |
| JP2023519231A (ja) | 2023-05-10 |
| EP3885339A1 (en) | 2021-09-29 |
| EP4126821B1 (en) | 2024-05-15 |
| AU2021245014A1 (en) | 2022-10-27 |
| US20230127805A1 (en) | 2023-04-27 |
| WO2021191062A1 (en) | 2021-09-30 |
| AR121654A1 (es) | 2022-06-29 |
| TW202140423A (zh) | 2021-11-01 |
| EP4126821A1 (en) | 2023-02-08 |
| ES2986976T3 (es) | 2024-11-13 |
| CA3172903A1 (en) | 2021-09-30 |
| KR20220160031A (ko) | 2022-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38147A (es) | Proceso de preparación | |
| IL286036A (en) | Process for preparing 2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((9-(4-chlorophenyl)-3-(1,3-difluoropropan-2-yl)-3-azaspiro[5.5]undec-8-en-8-yl)methyl)piperazin-1-yl)benzoic acid | |
| PL4126821T3 (pl) | Sposób wytwarzania kwasu (r)-4-(1-(6-(4-(trifluorometylo)benzylo)-6-azaspiro[2.5]oktano-5-karboksyamido)cyklopropylo)benzoesowego lub jego soli | |
| MX2025010774A (es) | Formas en estado solido | |
| EP4467143A3 (en) | 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorobenzonitrile as antiproliferative compound | |
| PL2099297T3 (pl) | Środki poprawiające zgodność dla preparatów herbicydów zawierających sole kwasu 2,4-(dichlorofenoksy)octowego | |
| NO20061420L (no) | 3-[(2-{4-Heksyloksykarbonylamino-Imino-metyl)-Fenylamino]-Metyl}-1-Metyl-1H-Benzimidazol-5-Karbonyl)-Pyridin-2-yl-Amino]-Propansyre Etylester Metansulfonat og | |
| NO20052755D0 (no) | Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse. | |
| ES3059967T3 (en) | Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl) benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | |
| WO2001064645A3 (en) | Derivatives of quinoline as alpha-2 antagonists | |
| WO2007056219A3 (en) | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto | |
| MXPA04002036A (es) | Hidratos cristalinos de derivados de anilida de acido nicotinico. | |
| ZA202106437B (en) | Compound form having enhanced bioavailability and formulations thereof | |
| IL284665A (en) | Pharmaceutical compounds consisting of (S)-4- (4- (4- (((2- (2,6-dioxopyridin-3-yl)-1-oxoisoinolin-4-yl)oxy)methyl)benzyl)piperazine-1- YL)-3-fluorobenzonitrile and methods of using the same | |
| DK276986D0 (da) | Fremgangsmaade til fremstilling af herbicide 2-(4,4-disubstitueret-5-oxo-2-imidazolin-2-yl)benzoesyre, -nikotinsyre og -quinolin-3-carboxylsyre, estere og salte deraf | |
| IL303408A (en) | Method for preparing 2-hydroxy-5-[2-(4-trifluoromethylphenyl)ethylamino)]benzoic acid | |
| Hamaguchi et al. | Addressing phototoxicity observed in a novel series of biaryl derivatives: Discovery of potent, selective and orally active phosphodiesterase 10A inhibitor ASP9436 | |
| CN110769825A (zh) | 一种含有喹啉衍生物的药物组合物 | |
| DK4178548T3 (da) | Farmaceutiske sammensætninger omfattende (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUORBENZONITRIL | |
| MX2022005864A (es) | Formas cristalinas de un inhibidor de magl. | |
| IL152681A0 (en) | Process for the preparation of 4-(4-pyridinyl)benzoic acid, or a salt thereof | |
| MXPA05009122A (es) | Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso. | |
| DK1497290T3 (da) | Fremgangsmåde til fremstilling af syresalte af gemifloxacin | |
| IL147043A0 (en) | Quinolinecarboxylic acid derivative or salts thereof | |
| WO2003013530A3 (de) | Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten |